Until we define clear biomarkers, Lupus and related autoimmune diseases will remain shifting sands, and experts don't help either, just read the statement pertaining to how to categorize:
ON LUPUS
"Several instruments have been developed for this purpose, including the British Isles Lupus Assessment Group (BILAG) index,[13] the European Consensus Lupus Activity Measurement (ECLAM),[14] and the SLE Disease Activity Index (SLEDAI).[15]" (MEDSCAPE)
how to compare the outcomes is also subsequently in flux
genetic biomarkers are still in the works!
No comments:
Post a Comment